New Research Compares Drug Regulators Around the Globe
By Zachary Brennan -
Published 11 August 2017
Pharmaceutical regulations vary widely in different countries, though new research published Friday in Nature Reviews Drug Discovery offers comparisons in terms of various regulators’ budgets, staff, new drug approvals and timelines for approvals.
Categories: News, Asia, Canada, Europe, US, Anvisa, CFDA, EMA, FDA, MHRA, PMDA, Government affairs, Regulatory intelligence, Regulatory strategy
Tags: comparison of drug regulators, new drug approval times, drug regulator reviewers